Rising Prevalence Of Infectious Diseases To Drive Market Growth: A Key Catalyst Accelerating Global Viral Inactivation Market Growth in 2025

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Viral Inactivation Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market concerned with viral inactivation has experienced substantial expansion recently, projected to increase from a valuation of $5.01 billion in 2024 to $5.47 billion the following year, marking a compound annual growth rate of 9.2%; this upward trajectory during the past period stems from several factors including the worldwide increase in air travel volume, advances in navigational technology, the flourishing commercial aviation sector, cost efficiencies realized by airlines, enhancements to operational safety in flight, and a decrease in the tasks required of pilots.

Viral Inactivation Market Size Forecast: What's the Projected Valuation by 2029?
Anticipation surrounds the viral inactivation sector, projecting swift expansion in the forthcoming years, culminating in a market valuation of $8.24 billion by 2029, bolstered by a compound annual growth rate (CAGR) reaching 10.8%. This upward trajectory over the projection timeframe is principally driven by advancements in autonomous flight technologies, the realization of novel aircraft architectures, proactive undertakings toward establishing sustainable aviation practices, the proliferation of urban air mobility (uam) solutions, and a mounting requirement for airborne vehicles. Key directional shifts poised to influence the market during this period encompass the incorporation of sophisticated avionics systems, the deployment of artificial intelligence capabilities, novel developments in human-machine interface (hmi) technology, the process of upgrading current aircraft fleets, and deeper integration of global navigation satellite system (gnss) technologies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/viral-inactivation-global-market-report

What Are the Drivers Transforming the Viral Inactivation Market?
The escalating frequency of diverse communicable illnesses is anticipated to be a major stimulus for the expansion of the viral inactivation sector in the coming period. These transmissible ailments manifest when conditions pass between persons via contaminated consumables like food and drink, or through the presence of harmful agents such as viruses, bacteria, fungi, and parasites. Since viral inactivation techniques utilize chemical agents and physical methods for pathogen eradication, they are extensively utilized in initiatives aimed at managing human diseases to halt the transmission of catching viral outbreaks, thereby fueling market expansion in this domain. To illustrate this trend, data released by the US national public health institution, the Centers for Disease Control and Prevention, in March 2024 indicated that tuberculosis occurrences rose by 1,295 cases, escalating from 8,320 in 2022 to 9,615 by 2023; concomitantly, the incidence rate shifted from 2.5 per 100,000 individuals recorded in 2022 to 2.9 per 100,000 in 2023, demonstrating that the rising prevalence of numerous infectious diseases is therefore propelling the market for viral inactivation forward.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10401&type=smp

What Long-Term Trends Will Define the Future of the Viral Inactivation Market?
A prominent development within the viral inactivation sector involves the growing incorporation of sophisticated technological methods, a trend that market participants are embracing to maintain competitive standing; an illustration of this is the March 2022 introduction of the Tetracycline-Enabled Self-Silencing Adenovirus (TESSA) Technology by WuXi Advanced Therapies, which operates as a subsidiary fully owned by the Chinese biopharmaceutical firm WuXi AppTec, where this state-of-the-art approach facilitates the sanctioning of novel therapeutics by consolidating crucial procedures such as assay formulation, biosafety assessments, viral clearance studies, product release testing, and general testing, allowing all these evaluations to be executed concurrently and internally; fundamentally, this represents a fresh, inventive means for fabricating adeno-associated virus (AAV) material meeting Good Manufacturing Practices (GMP) standards without requiring the use of transfection.

Which Segments in the Viral Inactivation Market Offer the Most Profit Potential?
The viral inactivationmarket covered in this report is segmented -

1) By Product: Kits And Reagents; Systems; Services
2) By Method: Solvent Detergent Method; pH Adjustment Method; Pasteurization; Other Methods
3) By Application: Vaccines And Therapeutics; Tissues And Tissue Products; Blood And Blood Products; Other Applications
4) By End User: Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Blood Banks; Hospital; Academic Research Institutes; Other End Users

Subsegments:
1) By Kits And Reagents: Viral Inactivation Kits; PCR Reagents; Antibodies and Enzymes
2) By Systems: Automated Viral Inactivation Systems; Batch Viral Inactivation Systems; Continuous Flow Systems
3) By Services: Viral Testing Services; Validation Services; Consulting Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10401&type=smp

Which Firms Dominate the Viral Inactivation Market by Market Share and Revenue in 2025?
Major companies operating in the viral inactivation market include Merck & Co. Inc., Sartorius AG, Texcell SA, SGS SA, Charles River Laboratories Inc., Clean Cells SAS, Rad Source Technologies, WuXi AppTec, Sigma-Aldrich Co. LLC, Thermo Fisher Scientific Inc., Macopharma, Cerus Corporation, TERUMO BCT INC., Shandong Weigao Group Medical Polymer Co. Ltd., Pall Corporation And Eurofins Scientific, General Electric Company, Cytiva, Mettler Toledo, Viral Inactivated Plasma Systems SA, Eurofins Scientific SE, Lonza Group AG, Avantor Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Fujifilm Holdings Corporation, Pfizer Inc., Novartis AG, Gilead Sciences Inc., Johnson & Johnson Private Limited

Which Regions Offer the Highest Growth Potential in the Viral Inactivation Market?
North America was the largest region in the viral inactivation market in 2024. Asia-pacific is expected to be the fastest-growing region in the global viral inactivation market during the forecast period. The regions covered in the viral inactivation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10401

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.